ClinicalTrials.gg
Not yet recruitingNCT07947979Updated Nov 19, 2026

The Effect of 'Mindfulness of Breathing' on Chronic Migraine

An interventional study of Mindfulness of breathing and Sham Meditation in Chronic Migraine Headache, sponsored by Dr. Ram Manohar Lohia Hospital. Not yet recruiting. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-11-19.

Sponsored by Dr. Ram Manohar Lohia Hospital · Not applicable, Interventional, and Health services research

How we know

Updated Nov 19, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Study summary

Migraine is a common disabling primary headache disorder ranked as the third most prevalent disorder in the world. Chronic migraine (CM) is described as a headache occurring on 15 or more days/month for more than 3 months, which, on at least 8 days/month, has the features of a migraine headache. Chronic migraine typically evolves from episodic migraine with an annual progression rate of \~3%. CM is an important treatable cause of neurological disability . It impacts, on an average, 1.4-2.2% of the global population and imposes a significant individual and socioeconomic burden with disability scores reported to be nearly twice as high.

It is vital to make a diagnosis and ensure that any concomitant medical or psychological conditions are treated in parallel with interventions aimed at reducing the biological tendency to headaches. The conventional treatment for migraine therapy is medical therapy. However only half of the patients respond to medications and preventive drug treatments; and about 10% discontinue medications due to adverse events. Moreover almost half of the patients are not satisfied with the present treatment. There is a clear need for additional preventive strategies in the current treatment regimens for migraines due to existing shortcomings of medical management of CM. In addition, there are other tactics that can be used, such as practicing alternative medicine through Yoga and Meditation.

Meditation has been found to help in reducing stress and changing the psychological state of a person. Mindfulness meditation has been derived from Vipassana, an age old meditation technique and has been practiced since long. Buddhist literature has detailed description about the techniques of Vipassana. Mindfulness of Breathing called as 'Anapanasati Meditation', in Buddhist scriptures is the first step in the practice of Vipassana meditation. It is a technique that involves observing natural and normal breathing. As it enters and exits the body our breath acts as a connection between our conscious and unconscious minds and the voluntary and involuntary processes of our body. By observing our breath, we can gain insight into the nature of our mind and its tendency to be inconsistent and fleeting.Slowly, this technique helps develop concentration of the mind and become calm. . It is a simple and scientific method that can be easily learned. Using Mindfulness of Breathing (Anapanasati) as a tool to reduce stress can be helpful in reducing the disability associated with migraines, as stress is a common trigger for migraines.

In the present study we aim to evaluate the beneficial effects of this simple meditation technique in management of CM.

02

Conditions studied

  • Chronic Migraine Headache

Browse trials for

Keywords

  • Chronic Migraine, Anapana Meditation, Mindfulness of Breathing
03

In context

Migraine Disorders

1,660 studies on the registry are indexed under Migraine Disorders; 340 are open to participants now.

This study's planned enrollment of 80 is close to the median of 80 across 1,270 interventional studies indexed under Migraine Disorders.

Browse Migraine Disorders studies →

Lead sponsor

Dr. Ram Manohar Lohia Hospital is the lead sponsor of 10 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria:-1. All patients between 18-60 years of age fulfilling the criteria for chronic migraine as defined by ICHD -3.3 2. Patients willing to carry out meditation as prescribed. 3. Patients on a maximum of one concomitant preventive medication for not less than 3 months duration and a stable dose for at least 1 month prior to randomization.

Exclusion Criteria:-1. 1.Patients \< 18 years and > 60 years of age. 2. Prior Neurologic diseases like brain tumors, dementia, seizures, encephalitis, meningitis, and stroke. 3. Patients overusing barbiturate-containing analgesics, opioids, or subjects with medical conditions attributable to medication overuse (e.g. peptic ulcer disease from overuse of nonsteroidal anti-inflammatory drugs [NSAIDS]).

4. Patients who did not complete the headache diary for more than 6 non-consecutive days during the baseline period.

05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
80 participants (estimated)

Study arms

  • Experimental
    Supervised Meditation Group

    The 'Meditation' group will take part in structured 'Mindfulness of Breathing' meditation sessions. A total of five sessions will be conducted on days 0, 7, 14, 28 and week 8th at the Yoga Department of ABVIMS and Dr RML Hospital. These sessions will be supervised by a yoga instructor who will explain the procedure and answer any queries. The patients will then practice the meditation alongside the instructor, as described in the subsequent sections. They will also be encouraged to continue this practice daily at home, using a 20-minute audio guide featuring the voice of the 'Late Shri S.N. Goenka Ji'. Additionally, the 'Meditation group' will join a WhatsApp group for enhanced supervision by the Yoga instructor, in which members will be required to provide daily updates after their meditation sessions. If they fail to report their daily meditation, the admin would remind them to ensure that they complete it, and their queries and issues will also addressed.

    Behavioral: Mindfulness of breathing

  • Sham comparator
    Unsupervised Meditation Group

    The Unsupervised meditation/Sham group will practice meditation on their visits-on days 0, 7, 14, 28, and week 8-without any supervision. The Yoga instructor will merely guide them once to independently concentrate on their breathing. They will not be provided any audio. This will serve as a sham group for more effective comparison and ensured blinding.

    Behavioral: Sham Meditation

Interventions

  • BehavioralMindfulness of breathing

    The technique taught by the late Shri S.N. Goenka Ji involved sitting with closed eyes in a quiet room with minimal distractions, maintaining a comfortable posture with the spine straight and hands resting on the thighs, without requiring any specific mudra for 20 minutes daily.The practitioner will have to observe the breath as instructed, without judging its length or type. The nature of the breath will have to be accepted as it is and should not be altered. Any thoughts that arise are to be acknowledged without judgment. If the mind wanders, one has to notice this and gently shift awareness back to the breath without clinging to it or wishing it to be different. If any pain, discomfort, or other sensations are felt, these are to be acknowledged with awareness before returning attention to the breath. The subject simply follows the instructions of a pre-recorded 'Mindfulness of Breathing Meditation (Anapana)' audio provided by the yoga instructor throughout the sessions.

  • BehavioralSham Meditation

    Patients were told to meditate on their own .They were not provided with any structured meditation technique. They were told to meditate in a quiet room with minimal distractions, maintaining a comfortable posture with the spine straight and hands resting on the thighs, without requiring any specific mudra for 20 minutes daily on their own without any specific instructions.

06

What researchers measure

Primary outcomes

  1. To assess the change in headache days at 12 weeks from baseline.

    Change in frequency of moderate-severe headache days per month from baseline (Headache-day is defined as a calendar day \[00:00 to 23:59\] when the patient reported \> 4 continuous hours of headache in the diary) during the month 2-3.

    Time frame: From enrollment to 12 Weeks.

Secondary outcomes

  1. Change in migraine days (week 8 - 12 vs baseline)

    Time frame: 12 weeks

  2. 50% responder rate

    Time frame: 12 weeks

Other outcomes

  1. Change in headache severity (week 8 - 12 vs baseline)

    Time frame: 12 weeks

  2. Change in number of days with acute medication use (week 8 - 12 vs baseline)

    Time frame: 12 weeks

  3. Change in PHQ-9 scores (week 8 - 12 vs baseline)

    Time frame: 12 weeks

  4. Change in MIDAS score ( week 8-12 vs baseline)

    Time frame: 12 weeks

  5. Change in HIT (week 8-12 vs baseline)

    Time frame: 12 weeks

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Yes — IPD related to the study will be shared by the principal investigator on request.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Nov 2026; primary completion for Aug 2027, 9 months later.

Of 309 non-industry interventional studies with no phase under Migraine Disorders, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 36. This study's planned 9 months is below that.

Counting every sponsor, half of 359 studies reached it within 15 months; a quarter within 7 and three quarters within 34.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 13, 2026
First posted
Nov 19, 2026
StartEst.
Nov 15, 2026
Primary completionEst.
Aug 15, 2027
CompletionEst.
Aug 15, 2027
Last update
Nov 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 19, 2026
Show all 1 update
  1. Nov 19, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07947979
Lead sponsor
Dr. Ram Manohar Lohia Hospital
Responsible party
Dr Ashish Kumar Duggal (Professor, Dr. Ram Manohar Lohia Hospital) — Principal investigator
First posted
Nov 19, 2026
Start date
Nov 15, 2026 (estimated)
Primary completion
Aug 15, 2027 (estimated)
Completion
Aug 15, 2027 (estimated)
Last update
Nov 19, 2026

Study contacts

Ashish Kumar Duggal, DM
Contact
ashishduggal2005@gmail.com
9810523332 ext. +91
Kumari Archana, DM
Contact
singharchana06@gmail.com
8820924289 ext. +91

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion